What's new

Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Date of authorisation: 11/11/2016, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Date of authorisation: 11/11/2016, Revision: 20, Status: Authorised

Apr 1, 2025 - 15:05
 0
Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Date of authorisation: 11/11/2016, Revision: 20, Status: Authorised
Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Date of authorisation: 11/11/2016, Revision: 20, Status: Authorised
Read More

Tags:

Previous Article

Porsche Will Now Give You a Tattoo of Your New Car

Next Article

BBU debuts new Little Bites muffin varieties

Related Posts

Human medicines European public assessment report (EPAR): Qoyvolma, ustekinumab, Status: Opinion

Human medicines European public assessment report (EPAR...

Mar 28, 2025  0

Human medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 14, 2025  0

Orphan designation: adeno-associated virus vector serotype SNY001 containing the human PAH gene Treatment of hyperphenylalaninaemia, 26/02/2025 Positive

Orphan designation: adeno-associated virus vector serot...

Mar 11, 2025  0